In complex diseases, such as cancer and viral infection, multiple signaling pathways or mechanisms are involved. At Alphamab Oncology, we have developed two proprietary technical approaches to provide innovative
solutions to address this growing trend in the development of modern
biotherapeutics.
INNOVATIVE PORTFOLIO WITH SIGNIFICANT POTENTIAL AND MITIGATED DEVELOPMENT RISK
Leveraging its proprietary technology platforms, Alphamab Oncology has developed an exciting portfolio of pipeline programs with clear
differentiation and global competitiveness.
IN-HOUSE cGMP MANUFACTURING WITH A SOLID TRACK RECORD
The production of biologics, such as antibody drugs, is a complex, lengthy and costly process. We have been establishing our own cGMP production facilities to address the manufacturing issues which have plagued many biotech companies in developing biotherapeutics.
Proprietary Platforms
Innovative Pipeline
Biologics Manufacturing
